Calretinin as a blood-based biomarker for mesothelioma

BACKGROUND: Malignant mesothelioma (MM) is a deadly cancer mainly caused by previous exposure to asbestos. With a latency period up to 50 years the incidence of MM is still increasing, even in countries that banned asbestos. Secondary prevention has been established to provide persons at risk regula...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnen, Georg, Gawrych, Katarzyna, Raiko, Irina, Casjens, Swaantje, Pesch, Beate, Weber, Daniel G., Taeger, Dirk, Lehnert, Martin, Kollmeier, Jens, Bauer, Torsten, Musk, Arthur W., Robinson, Bruce W. S., Brüning, Thomas, Creaney, Jenette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450182/
https://www.ncbi.nlm.nih.gov/pubmed/28558669
http://dx.doi.org/10.1186/s12885-017-3375-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450182/
https://www.ncbi.nlm.nih.gov/pubmed/28558669
http://dx.doi.org/10.1186/s12885-017-3375-5

Ejemplares similares